Unity Biotechnology Inc (NASDAQ: UBX) open the trading on Wednesday, with great promise as it jumped 16.76% to $2.09, before settling in for the price of $1.79 at the close. Taking a more long-term approach, UBX posted a 52-week range of $0.94-$2.02.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -48.77%. Meanwhile, its Annual Earning per share during the time was 36.93%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 49.22%. This publicly-traded company’s shares outstanding now amounts to $16.85 million, simultaneously with a float of $15.37 million. The organization now has a market capitalization sitting at $35.21 million. At the time of writing, stock’s 50-day Moving Average stood at $1.2700, while the 200-day Moving Average is $1.4200.
Unity Biotechnology Inc (UBX) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Unity Biotechnology Inc’s current insider ownership accounts for 8.80%, in contrast to 13.14% institutional ownership. According to the most recent insider trade that took place on Nov 04 ’24, this organization’s Chief Executive Officer sold 432 shares at the rate of 1.29, making the entire transaction reach 557 in total value, affecting insider ownership by 75,893. Preceding that transaction, on Nov 04 ’24, Company’s CFO & Head of Corp. Dev. sold 136 for 1.29, making the whole transaction’s value amount to 175. This particular insider is now the holder of 55,925 in total.
Unity Biotechnology Inc (UBX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
Unity Biotechnology Inc’s EPS increase for this current 12-month fiscal period is 49.22% and is forecasted to reach -1.01 in the upcoming year.
Unity Biotechnology Inc (NASDAQ: UBX) Trading Performance Indicators
Let’s observe the current performance indicators for Unity Biotechnology Inc (UBX). It’s Quick Ratio in the last reported quarter now stands at 3.45. The Stock has managed to achieve an average true range (ATR) of 0.19.
In the same vein, UBX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.32, a figure that is expected to reach -0.39 in the next quarter, and analysts are predicting that it will be -1.01 at the market close of one year from today.
Technical Analysis of Unity Biotechnology Inc (UBX)
[Unity Biotechnology Inc, UBX] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 76.36% While, its Average True Range was 0.2200.
Raw Stochastic average of Unity Biotechnology Inc (UBX) in the period of the previous 100 days is set at 91.27%, which indicates a major rise in contrast to 91.27% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 235.18% that was higher than 103.16% volatility it exhibited in the past 100-days period.
